Foamix Ltd. and Therapeutics Inc. Enter into Joint Venture to Develop New Prescription Foams for Inflammatory Skin Diseases

US Grant for Foamix's Saccharide Foam Patent - Topical "Sweet Foam" Products for Wound & Burn Therapy

Foamix is a Finalist for the Red Herring 100 Global Award for Most Promising Technology Ventures

Dermatology co Foamix teams with Switzerland's Galderma

Foamix Expands International Patent Protection for its Emollient Foam Platform

Foamix Extends Collaboration with Galderma

Foamix Ltd. and VIB Sign Co-Development Agreement for Innovative Topical Therapy for Psoriasis

Promius Pharma, LLC Launches Scytera™ (Coal Tar) Foam 2% for Treatment of Psoriasis

Foamix is Finalist for International 2008 SCRIP Award

Ferndale and Foamix Execute License Agreement for Development of Non-Steroidal Foam for Atopic Dermatitis

Omnibus Survey:72% of Women Are Dissatisfied with Their Current Treament of Vaginal Infection

Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases

Foamix is a finalist for the Red Herring 100 Europe 2008 Award

BIRD invests $14m in 16 joint projects; English Hebrew

Foamix Announces New Foam Patent Approvals

Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis

Foamix Acquires Rights to Dual Chamber Aerosol Foam Technology

In-Pharma Technologist.com: Best Foam Forward

Foamix presents Innovative Intra-Vaginal Foam Delivery for Gynecology

Foamix Signs R&D Collaboration and License Agreement with Dr. Reddy’s for the Development and Commercialization of Psoriasis Foam

YNET: Collaboration with Warner Chilcott on gynecologic treatment (article in Hebrew)

Warner Chilcott and Foamix Collaborate on Gynecologic Foam Product

Foamix and Intendis Sign License Agreement for the Development of a Dermatological Foam

Globes: Foamix collaborates with Warner Chilcott on acne treatment

Warner Chilcott and Foamix Collaborate on Foam Product for the Treatment of Acne


 
Our Team


Dov Tamarkin
Meir Eini
David Schuz
Lior Kadosh

The Foamix management team comprises highly qualified professionals with extensive managerial and research experience in the fields of dermatology, cosmetics and biopharmaceuticals.

Dov Tamarkin, Ph.D. - CEO
Dr. Tamarkin is a co-founder of the Company and co-inventor of the Foamix Oil Gel and Foam technologies.
He has more than seventeen years experience in the direction of preclinical, clinical and regulatory phases of drug development. He has held senior positions at Teva Pharmaceuticals and Teva’s subsidiary Portman Pharmaceuticals. Dr. Tamarkin also has extensive experience in the set-up and management of start-up pharma companies and in business development.
He holds a Ph.D. degree in chemistry from The Hebrew University of Jerusalem, Israel and is the inventor of numerous patents in the pharmaceutical field.

Meir Eini - Chairman & COO
Meir Eini is a co-founder of the Company and co-inventor of the Foamix Foam and Oil Gel technologies. He is an experienced entrepreneur and he has many years of experience in the initiation, setting-up and running of technology-oriented businesses in Israel and the U.S.
Mr. Eini is an inventor of 25 patents in the fields of healthcare, food and medical equipment.

David Schuz, M.Phil., Dip. Pharm., L.LM. - Senior Vice President, Intellectual Property
Mr. Schuz is responsible for managing IP affairs including Foamix’s expanding patent and trademark portfolio as well as directing IP strategy and IP due diligence. Mr. Schuz acquired his legal and intellectual property education at LSE, University of London, QMW, University of London and the University of Trent, Nottingham, UK. He also holds an M. Phil. Degree in Biochemistry and a Diploma of Pharmacology from the University of Cambridge.
Mr. Schuz served as Vice President, Legal at Bio-Technology General (Israel) Ltd. He also served at various times as Acting General Counsel, Associate General Counsel, Senior Director and Head of IP Worldwide at Savient Pharmaceuticals Inc.

Lior Kadosh, Eng. - Vice President, Operations
Mr. Kadosh is responsible for the Company’s operation, including administration, supply chain management, budgeting, IT, maintenance and human resources. He has over 15 years of industrial experience.
Mr. Kadosh holds a M.Sc. degree in Industrial & Management Engineering from Ben Gurion University.

The Foamix executive and scientific team has achieved major tasks, including the development of multiple technology platforms, writing up several patent applications and evoking the interest of a number of strategic partners. Due to the broadening of the Company’s scope of action, Foamix is currently expanding its activities and is adding experienced scientists and business-development personnel to the team.